Recent studies indicate that the GLP-1 mimetic, a synthetic molecule, could be a potentially beneficial medicinal strategy for several diseases. Compared to traditional GLP-1 agonists, this molecule suggests to offer enhanced stability and possibly fewer negative consequences. Further investigat